• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 GLIDEPATH; DIALYSIS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 GLIDEPATH; DIALYSIS CATHETER Back to Search Results
Catalog Number 5393230
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Codes Cardiac Arrest (1762); Exsanguination (1841)
Date of Event 02/25/2022
Type of Reportable Event Death
Additional Manufacturer Narrative
H10: as the lot number for the device was provided, a review of the device history records will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that during a scheduled hemodialysis treatment through the hemodialysis central venous catheter, the nurse identified a pool of blood of approximately 100-300ml under the patient's chair during the first several minutes of treatment initiation.It was further reported that the blood pump was stopped, and it was discovered that the blood loss was originating from the venous bloodline/venous lumen connection site.Reportedly, the patient's carotid pulse was palpable, hemodialysis treatment was terminated, and blood was returned using arterial lumen of the catheter.The patient became unresponsive, the emergency response services was called, and cpr was initiated.Upon arrival, the emergency response services continued resuscitative efforts while transporting the patient to the hospital.The patient reportedly expired shortly after.
 
Additional Manufacturer Narrative
H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.Investigation summary: the physical device was not returned for evaluation.No photos or medical records were provided for review.Therefore, the investigation is inconclusive for the reported fluid leak and patient death, as no objective evidence was provided for review.A definitive root cause for the reported fluid leak and patient death could not be determined based upon the provided information.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that during a scheduled hemodialysis treatment through the hemodialysis central venous catheter, the nurse identified a pool of blood of approximately 100-300ml under the patient's chair during the first several minutes of treatment initiation.It was further reported that the blood pump was stopped, and it was discovered that the blood loss was originating from the venous bloodline/venous lumen connection site.Reportedly, the patient's carotid pulse was palpable, hemodialysis treatment was terminated, and blood was returned using arterial lumen of the catheter.The patient became unresponsive, the emergency response services was called, and cpr was initiated.Upon arrival, the emergency response services continued resuscitative efforts while transporting the patient to the hospital.The patient reportedly expired shortly after.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GLIDEPATH
Common Device Name
DIALYSIS CATHETER
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key21382474
Report Number3006260740-2025-00653
Device Sequence Number20905821
Product Code MSD
UDI-Device Identifier00801741012181
UDI-Public(01)00801741012181(11)191122(17)210831(10)REDX3944
Combination Product (Y/N)N
Initial Reporter StateAZ
Initial Reporter CountryUS
PMA/510(K) Number
K051748
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/23/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/31/2021
Device Catalogue Number5393230
Device Lot NumberREDX3944
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/27/2025
Supplement Date Received by Manufacturer05/23/2025
Initial Report FDA Received Date02/14/2025
Supplement Report FDA Received Date05/28/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured11/22/2019
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Death;
Patient Age59 YR
Patient SexFemale
Patient Weight63 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-